Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808151
What this trial is testing
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Who this might be right for
Colon CancerMicrosatellite Stable (MSS) Colon CancerProficient Mismatch Repair (pMMR) Colon Cancer
Solstice Oncology, Inc. 100